Publication:
Pegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B

Thumbnail Image

Files

file.pdf (66.89 KB)

Date

2007-08

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

AMER SOC MICROBIOLOGY

Research Projects

Organizational Units

Journal Issue

Abstract

Forty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additional 24 weeks. At the end of follow-up, virological response rates (HBV DNA levels of < 400 copies/ml) were similar in the monotherapy (24%) and combination therapy (26%) groups.

Description

Keywords

Citation

URI

https://hdl.handle.net/11424/242091

Collections

Araştırma Çıktıları

Endorsement

Review

Supplemented By

Referenced By